Patent · US Active

Engineered red-shifted channelrhodopsin variants

US8759492B2 · kind B2 · utility

1Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 17, 2012
Grant dateJun 24, 2014
Priority date—
Expiry dateDec 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides engineered red-shifted channelrhodopsin variants. In some embodiments, the channelrhodopsin variants are characterized by improved membrane trafficking, expression, and/or unique spectral and kinetic properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.